Insights from 2024 ESGO Annual Meeting
Playback speed
10 seconds
ESGO 2024 Insights: "IMAGYN-050 Trial - Benefit From Atezolizumab in Pts With a Poor Prognostic Ovarian Cancer in 1L Setting"
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Benoit You
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Benoit You
82 views
March 22, 2024
Comments 0
Login to view comments.
Click here to Login
Videos